Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
Biliary Tract Cancers: Is Laparoscopic Liver Resection Adequate?
Read More
Cholangiocarcinoma
The Future of Neoadjuvant Chemotherapy for iCCA
Read More
Cholangiocarcinoma
Mayo Clinic Study Assessed Impact of Neoadjuvant Chemoradiation in Patients with Unresectable Perihilar CCA
Read More
Cholangiocarcinoma
,
Radiation Therapy
Impact of Liver-Directed Radiation Therapy in Patients with Metastatic iCCA
Read More
Cholangiocarcinoma
Addition of Toripalimab to Standard Chemotherapy Gemcitabine plus S-1 for the First-Line Treatment of Advanced BTCs
Read More
Cholangiocarcinoma
Results from the STAMP Study: Adjuvant GemCis versus Capecitabine in Patients with Resected Lymph Node–Positive eCCA
Read More
Cholangiocarcinoma
Assessment of QOL in BTC Clinical Trials: A Systematic Review
Read More
Cholangiocarcinoma
Immune-Related AEs in the TOPAZ-1 Study of Durvalumab plus GemCis in Advanced BTC
Read More
Cholangiocarcinoma
2022 Year in Review: Cholangiocarcinoma
Read More
Cholangiocarcinoma
Results from the ABC-06 Trial: Tumor Markers in Advanced BTCs Treated with Second-Line Active Symptom Control Alone or in Combination with FOLFOX
Read More
39
40
41
42
43
44
45
Page 42 of 196
Results 411 - 420 of 1953
